Cerus Net Profit Margin 2010-2024 | CERS
Cerus net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Cerus Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.20B | $-0.02B | -10.89% |
| 2024-09-30 | $0.20B | $-0.02B | -10.10% |
| 2024-06-30 | $0.19B | $-0.02B | -12.37% |
| 2024-03-31 | $0.19B | $-0.03B | -16.23% |
| 2023-12-31 | $0.19B | $-0.04B | -19.89% |
| 2023-09-30 | $0.18B | $-0.05B | -27.17% |
| 2023-06-30 | $0.18B | $-0.05B | -27.87% |
| 2023-03-31 | $0.18B | $-0.05B | -25.14% |
| 2022-12-31 | $0.19B | $-0.04B | -22.34% |
| 2022-09-30 | $0.19B | $-0.04B | -19.79% |
| 2022-06-30 | $0.18B | $-0.04B | -22.40% |
| 2022-03-31 | $0.17B | $-0.05B | -27.75% |
| 2021-12-31 | $0.16B | $-0.05B | -33.13% |
| 2021-09-30 | $0.14B | $-0.06B | -40.28% |
| 2021-06-30 | $0.13B | $-0.06B | -45.80% |
| 2021-03-31 | $0.12B | $-0.06B | -50.00% |
| 2020-12-31 | $0.12B | $-0.06B | -51.30% |
| 2020-09-30 | $0.11B | $-0.06B | -57.94% |
| 2020-06-30 | $0.10B | $-0.07B | -65.35% |
| 2020-03-31 | $0.10B | $-0.07B | -71.88% |
| 2019-12-31 | $0.09B | $-0.07B | -77.42% |
| 2019-09-30 | $0.09B | $-0.07B | -81.61% |
| 2019-06-30 | $0.08B | $-0.07B | -80.72% |
| 2019-03-31 | $0.08B | $-0.06B | -77.50% |
| 2018-12-31 | $0.08B | $-0.06B | -76.00% |
| 2018-09-30 | $0.07B | $-0.05B | -70.27% |
| 2018-06-30 | $0.07B | $-0.05B | -75.00% |
| 2018-03-31 | $0.06B | $-0.06B | -91.67% |
| 2017-12-31 | $0.05B | $-0.06B | -117.65% |
| 2017-09-30 | $0.04B | $-0.06B | -143.18% |
| 2017-06-30 | $0.04B | $-0.06B | -156.10% |
| 2017-03-31 | $0.04B | $-0.07B | -166.67% |
| 2016-12-31 | $0.04B | $-0.06B | -161.54% |
| 2016-09-30 | $0.04B | $-0.06B | -172.97% |
| 2016-06-30 | $0.04B | $-0.07B | -188.57% |
| 2016-03-31 | $0.04B | $-0.06B | -182.86% |
| 2015-12-31 | $0.04B | $-0.06B | -160.00% |
| 2015-09-30 | $0.04B | $-0.06B | -174.29% |
| 2015-06-30 | $0.04B | $-0.06B | -151.35% |
| 2015-03-31 | $0.04B | $-0.05B | -129.73% |
| 2014-12-31 | $0.04B | $-0.04B | -105.41% |
| 2014-09-30 | $0.04B | $-0.03B | -69.44% |
| 2014-06-30 | $0.04B | $-0.04B | -94.59% |
| 2014-03-31 | $0.04B | $-0.03B | -89.47% |
| 2013-12-31 | $0.04B | $-0.04B | -110.00% |
| 2013-09-30 | $0.04B | $-0.04B | -95.24% |
| 2013-06-30 | $0.04B | $-0.02B | -56.41% |
| 2013-03-31 | $0.04B | $-0.02B | -44.74% |
| 2012-12-31 | $0.04B | $-0.02B | -43.24% |
| 2012-09-30 | $0.04B | $-0.02B | -61.11% |
| 2012-06-30 | $0.04B | $-0.02B | -45.95% |
| 2012-03-31 | $0.04B | $-0.02B | -60.00% |
| 2011-12-31 | $0.03B | $-0.02B | -51.52% |
| 2011-09-30 | $0.03B | $-0.01B | -37.93% |
| 2011-06-30 | $0.03B | $-0.02B | -68.00% |
| 2011-03-31 | $0.02B | $-0.02B | -70.83% |
| 2010-12-31 | $0.02B | $-0.02B | -73.91% |
| 2010-09-30 | $0.02B | $-0.02B | -90.91% |
| 2010-06-30 | $0.02B | $-0.02B | -100.00% |
| 2010-03-31 | $0.02B | $-0.02B | -110.00% |
| 2009-12-31 | $0.02B | $-0.02B | -141.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.249B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.702B | 27.74 |
| Boston Scientific (BSX) | United States | $154.217B | 38.61 |
| Stryker (SYK) | United States | $145.561B | 30.44 |
| EssilorLuxottica (ESLOY) | France | $133.244B | 0.00 |
| Medtronic (MDT) | Ireland | $107.028B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.631B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.943B | 27.26 |
| ResMed (RMD) | United States | $35.287B | 26.50 |
| GE HealthCare Technologies (GEHC) | United States | $31.763B | 15.08 |
| Agilent Technologies (A) | United States | $30.897B | 20.41 |
| Terumo (TRUMY) | Japan | $29.152B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.100B | 17.21 |
| Insulet (PODD) | United States | $18.209B | 77.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.901B | 11.50 |
| Baxter (BAX) | United States | $15.608B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.425B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.395B | 18.18 |
| Bio-Rad Laboratories (BIO) | United States | $6.728B | 22.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.111B | 19.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.444B | 9.86 |
| ICU Medical (ICUI) | United States | $3.347B | 28.51 |
| Haemonetics (HAE) | United States | $3.139B | 14.77 |
| Envista Holdings (NVST) | United States | $2.876B | 23.90 |
| GN Store Nord (GNNDY) | Denmark | $2.071B | 17.15 |
| QuidelOrtho (QDEL) | United States | $1.868B | 15.64 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.63 |
| AtriCure (ATRC) | United States | $1.439B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.359B | 21.40 |
| Neogen (NEOG) | United States | $1.224B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.173B | 11.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.150B | 0.00 |
| InMode (INMD) | Israel | $0.991B | 9.08 |
| Phibro Animal Health (PAHC) | United States | $0.791B | 12.13 |
| Evolus (EOLS) | United States | $0.774B | 0.00 |
| Owens & Minor (OMI) | United States | $0.632B | 5.38 |
| Curaleaf Holdings (CURLF) | Canada | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.470B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.442B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.437B | 0.00 |
| Omeros (OMER) | United States | $0.397B | 0.00 |
| Surmodics (SRDX) | United States | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.348B | 15.09 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 26.18 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.265B | 47.20 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 14.80 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.178B | 4.06 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.91 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Exagen (XGN) | United States | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.61 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 59.50 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.31 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |